Registration NOW OPEN!
2025 ANA Clinical Trials Course
2025 ANA-NINDS Career Development Symposium
ANA2025 Support Opportunities
For ANA2025 sponsorship and exhibit opportunities, please contact Jennifer Summers, Meetings Manager at [email protected]
Testimonials
As I reflect on 20 years as Chair at Hopkins, there is simply no doubt that the ANA has played a huge role in providing me with an academic community, with continued personal guidance and career development, and with the inspiration to transform the lives of people with neurological disease.
Justin C McArthur, MBBS, MPH, FANA
John W. Griffin Professor
Professor of Neurology, Medicine, Epidemiology, and Pathology
Director, Department of Neurology
Neurologist-in chief, Johns Hopkins Hospital
Member, National Academy of Medicine
I have actively participated in ANA conference since my residency, becoming increasingly involved with each passing year. This conference has been a premier platform for showcasing groundbreaking scientific discoveries and talks from pioneers in the field. This conference has provided me invaluable opportunities, including travel scholarships that enabled me to present my research.
Richa Tripathi, MD (she/her)
Assistant Professor
Department of Neurology
Emory University
Attending the ANA 2024 was an unforgettable and enriching experience! From the moment I arrived, it was clear that this event was meticulously planned to bring together some of the brightest minds in neurology. The sessions were not only informative but also deeply inspiring, offering cutting-edge insights to the advancements in our field.
What stood out most was the genuine sense of community among attendees. Whether during breakout discussions, workshops, or networking events.
I can’t recommend ANA enough to my peers. It’s more than a conference—it’s a catalyst for growth, collaboration, and tangible advancements that positively impact the future of neurology and patient care.
Rohini Bhole, MD, MS, FAAN, FANA
Department of Neurology
Division of Vascular Neurology
University of Virginia
- 0
- 1
- 2
Support ANA2025!
ADVERTISE | EXHIBIT | SPONSOR
Exhibitors
Silver Sponsor
Sponsor
argenx is a global immunology company committed to improving lives of people suffering from severe autoimmune diseases. The company developed and is commercializing the first approved neonatal Fc receptor blocker in the U.S., Japan, Israel, EU, UK, Canada and China and advancing its autoimmune pipeline across multiple serious autoimmune diseases.
https://www.astrazeneca-us.com/
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries. Its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com or Twitter @AstraZeneca US.
Axsome Therapeutics is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.
Eisai Inc. is a human health care (hhc) company dedicated to pursuing innovative research and simplifying the treatment journey to help improve the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions. Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.
Our hhc mission is the shared purpose that connects us to those we serve. It creates a network of powerful relationships that enable us to identify, understand and address unmet needs and healthcare disparities as we work towards achieving societal good.
Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. Our U.S. operations include discovery, research and development; manufacturing; global supply and logistics; and commercial activities.
To learn more, please visit https://us.eisai.com and connect with us on X and LinkedIn. For more information on our research, follow our dedicated neurology (LinkedIn and X) and oncology (LinkedIn and X) pages.
https://www.endeavorhealth.org/
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com.
https://onlinelibrary.wiley.com/
Wiley champions those who see knowledge as a force for good. A trusted leader in research and learning, our pioneering solutions and services are paving the way for knowledge seekers as they work to solve the world’s most important challenges. Around the globe, we break down barriers for innovators, empowering them to publish and advance discoveries in their fields, evolve their workforces, and shape minds through teaching and learning. Together, we are unlocking the creation and curation of knowledge for all, transforming today’s biggest obstacles into tomorrow’s brightest opportunities.
https://www.neuroelectrics.com/
Neuroelectrics is a Spanish company pioneer in brain stimulation and artificial intelligence technologies and therapies to alleviate neurological diseases. The company currently offers the best-in class non-invasive and high-definition electrical brain stimulation technology for personalized neuromodulation. By measuring and modifying brain function, they aim to restore brain health, minimize disabilities, and create a better life for patients.
Founded in 2011 and headquartered in Barcelona and Boston, Neuroelectrics distributes its products in more than 70 countries for basic neuroscience and clinical research in hundreds of universities and academic medical centers. Their vision is to create a powerful neurotechnology platform upon which verticals can be developed to improve the lives of as many people as possible. Clinical applications are already being developed to diagnose and treat brain diseases as well as improve brain health (e.g., in epilepsy, neuropathic pain, or mood disorders) and cognitive function (e.g., memory in dementia or executive function in children with ADHD)
https://www.rosmansearch.com/home/rosman.html
RosmanSearch is a specialized physician recruitment firm with an edge. Our unique approach blends data-driven insights with a highly focused team of recruiters ensuring impactful placements. We don’t just fill positions; we lean on our expertise in neurosurgery, neurology, urology, gastroenterology and hospitalist medicine to curate matches that elevate healthcare standards. Whether permanent placement, executive search, or locum tenens, our experienced recruiters utilize robust data analytics and unparalleled expertise to ensure unmatched precision in every placement.
https://sorriditherapeutics.com
Sorridi Therapeutics has introduced NeuroFiber, containing 11g of prebiotic and whole food fibers in a tasty bar. NeuroFiber has been shown to reduce intestinal inflammation in Parkinson’s disease patients by improving the gut microbiome. Constipation was also reduced. Ex-vivo studies have shown a substantial increase in short chain fatty acids with NeuroFiber. In addition, NeuroFiber contains 3 vitamins known to be deficient in PD patients and has low protein content to minimize interference with PD medications
Sutter Health is a leading healthcare organization that provides high-quality, patient-centered care to communities in Northern California and other areas. With a network of hospitals, clinics, and physicians, Sutter’s divisions offer a wide range of services and specialties to meet the diverse needs of its patients. Sutter’s commitment to innovation and collaboration drives their success in delivering exceptional care and improving the health of their communities. To view current opportunities check us out at: https://jobs.sutterhealthclinicians.org/
The Lambert-Eaton LEMS Family Association is a 501c3 non-profit organization founded in 2022 to support the Lambert-Eaton Myasthenic Syndrome (LEMS) community of patients. We work to increase awareness of LEMS in the medical and research communities. We promote research with a dedicated, LEMS Patient Registry, hosted by Sanford Research (CoRDS). In addition, we strengthen community within our patient population with webinars and on-line meetings.
As part of The University of Texas at Austin, one of the nation’s leading research universities, the Dell Medical School pursues innovation in the redesign of healthcare delivery, excellence in healthcare research, and programs in interdisciplinary and inter-professional education. It is the fifth medical school in the UT System and the first medical school established in nearly five decades by a member of the Association of American Universities, an organization of leading public and private research universities.
The University of Texas Medical Center, anchored by Dell Medical School, is defining the future of health. Announced in August 2023 with planning and implementation underway, The University of Texas Medical Center will cement Austin as a premier destination for health care alongside other major Texas cities. With two new, state-of-the-art hospitals – A UT specialty hospital and a cancer center being built by MD Anderson – plus the academic and research expertise of UT, The University of Texas Medical Center will provide the integrated, world-class care that is a hallmark of academic medicine.
Axsome Therapeutics is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.
argenx is a global immunology company committed to improving lives of people suffering from severe autoimmune diseases. The company developed and is commercializing the first approved neonatal Fc receptor blocker in the U.S., Japan, Israel, EU, UK, Canada and China and advancing its autoimmune pipeline across multiple serious autoimmune diseases.
The Association of University Professors of Neurology (AUPN) was founded in 1967 and formally incorporated in 1968. It was organized originally to foster the development of academic neurology’s educational, research and patient care programs. The organization has always served as a forum for the Chairs of Departments or Divisions of Neurology in accredited medical schools in the United States, or similar programs in Canada, to discuss academic interests and challenges. The AUPN supports department chairs through its educational offerings that are geared toward the leaders in Neurology Departments including program directors and clerkship directors.
Axsome Therapeutics is developing therapies for CNS conditions with limited treatment options. By creating treatments with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing therapeutic approaches that meaningfully improve the lives of patients and provide additional options for physicians.
Eisai Inc. is a human health care (hhc) company dedicated to pursuing innovative research and simplifying the treatment journey to help improve the lives of people affected by cancer, Alzheimer’s disease and other neurodegenerative conditions. Everything we do is guided by the simple principle that patients and their families come first, and we have a responsibility to listen to and learn from them.
Our hhc mission is the shared purpose that connects us to those we serve. It creates a network of powerful relationships that enable us to identify, understand and address unmet needs and healthcare disparities as we work towards achieving societal good.
Eisai Inc. is the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd. Our U.S. operations include discovery, research and development; manufacturing; global supply and logistics; and commercial activities.
To learn more, please visit https://us.eisai.com and connect with us on X and LinkedIn. For more information on our research, follow our dedicated neurology (LinkedIn and X) and oncology (LinkedIn and X) pages.
Lilly is a medicine company turning science into healing to make life better for people around the world. We’ve been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than 51 million people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world’s most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer’s disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we’re motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram and LinkedIn.
https://onlinelibrary.wiley.com/
Wiley champions those who see knowledge as a force for good. A trusted leader in research and learning, our pioneering solutions and services are paving the way for knowledge seekers as they work to solve the world’s most important challenges. Around the globe, we break down barriers for innovators, empowering them to publish and advance discoveries in their fields, evolve their workforces, and shape minds through teaching and learning. Together, we are unlocking the creation and curation of knowledge for all, transforming today’s biggest obstacles into tomorrow’s brightest opportunities.
PRIME, a healthcare education and research company, offers continuing professional development for the interprofessional team while identifying and solving problems within health systems to facilitate optimal patient care. 30 + years of experience!
Sutter Health is a leading healthcare organization that provides high-quality, patient-centered care to communities in Northern California and other areas. With a network of hospitals, clinics, and physicians, Sutter’s divisions offer a wide range of services and specialties to meet the diverse needs of its patients. Sutter’s commitment to innovation and collaboration drives their success in delivering exceptional care and improving the health of their communities. To view current opportunities check us out at: https://jobs.sutterhealthclinicians.org/
EXPLORE BALTIMORE
Join us at the Baltimore Marriott Waterfront for ANA2025!
Experience Charm City like never before at Baltimore Marriott Waterfront. Ideally situated in the Harbor East neighborhood, our hotel in Baltimore, MD provides unparalleled access to Fells Point, the National Aquarium and the restaurants and shops of the Inner Harbor.
Countdown to ANA2025
See you in Baltimore!
Photo Gallery
